Bernd J. Schmitz‐Dräger

4.5k total citations
114 papers, 2.7k citations indexed

About

Bernd J. Schmitz‐Dräger is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Bernd J. Schmitz‐Dräger has authored 114 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Surgery, 32 papers in Pulmonary and Respiratory Medicine and 26 papers in Molecular Biology. Recurrent topics in Bernd J. Schmitz‐Dräger's work include Bladder and Urothelial Cancer Treatments (78 papers), Urinary and Genital Oncology Studies (48 papers) and Urological Disorders and Treatments (14 papers). Bernd J. Schmitz‐Dräger is often cited by papers focused on Bladder and Urothelial Cancer Treatments (78 papers), Urinary and Genital Oncology Studies (48 papers) and Urological Disorders and Treatments (14 papers). Bernd J. Schmitz‐Dräger collaborates with scholars based in Germany, United States and Canada. Bernd J. Schmitz‐Dräger's co-authors include Wolfgang A. Schulz, Michael J. Droller, Peter J. Goebell, Shahrokh F. Shariat, Andrea R. Florl, Roswitha Löwer, H. Barton Grossman, Yair Lotan, Núria Malats and Yves Fradet and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bernd J. Schmitz‐Dräger

111 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernd J. Schmitz‐Dräger Germany 26 1.7k 1.1k 501 488 371 114 2.7k
Hiroshi Eto Japan 28 521 0.3× 963 0.9× 513 1.0× 596 1.2× 432 1.2× 96 2.5k
T.R. Leyshon Griffiths United Kingdom 25 1.2k 0.7× 850 0.8× 474 0.9× 705 1.4× 275 0.7× 67 2.3k
Yasutomo Nakai Japan 23 539 0.3× 972 0.9× 879 1.8× 973 2.0× 617 1.7× 79 2.8k
Jeremy Crew United Kingdom 20 841 0.5× 609 0.6× 284 0.6× 393 0.8× 353 1.0× 54 1.7k
Toshihiko Kotake Japan 23 700 0.4× 619 0.6× 344 0.7× 532 1.1× 147 0.4× 87 1.8k
Miao‐Fen Chen Taiwan 30 770 0.5× 580 0.5× 844 1.7× 503 1.0× 326 0.9× 88 2.4k
Rainy Umbas Indonesia 19 403 0.2× 1.3k 1.2× 443 0.9× 798 1.6× 373 1.0× 68 2.2k
Frank Perabo Germany 23 406 0.2× 476 0.5× 308 0.6× 638 1.3× 385 1.0× 71 1.5k
Erik Veskimäe Finland 14 2.7k 1.6× 569 0.5× 695 1.4× 604 1.2× 307 0.8× 20 3.1k
Noboru Hara Japan 20 302 0.2× 467 0.4× 244 0.5× 615 1.3× 180 0.5× 106 1.4k

Countries citing papers authored by Bernd J. Schmitz‐Dräger

Since Specialization
Citations

This map shows the geographic impact of Bernd J. Schmitz‐Dräger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd J. Schmitz‐Dräger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd J. Schmitz‐Dräger more than expected).

Fields of papers citing papers by Bernd J. Schmitz‐Dräger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd J. Schmitz‐Dräger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd J. Schmitz‐Dräger. The network helps show where Bernd J. Schmitz‐Dräger may publish in the future.

Co-authorship network of co-authors of Bernd J. Schmitz‐Dräger

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd J. Schmitz‐Dräger. A scholar is included among the top collaborators of Bernd J. Schmitz‐Dräger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd J. Schmitz‐Dräger. Bernd J. Schmitz‐Dräger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goebell, Peter J., Ellen E. Paxinos, Jack Chen, et al.. (2024). Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study. Bladder Cancer. 10(1). 25–33.
2.
Saillard, Charlie, P Mann, Maxime Touzot, et al.. (2024). AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer. Nature Communications. 15(1). 10914–10914. 4 indexed citations
3.
Grimm, Marc‐Oliver, Martin Schostak, Wolfgang Loidl, et al.. (2023). 2372P Efficacy of a tailored approach with nivolumab (N) and nivolumab+ipilimumab (N+I) as immuno-therapeutic boost in metastatic urothelial carcinoma (mUC): Final results of TITAN-TCC. Annals of Oncology. 34. S1207–S1208. 1 indexed citations
4.
Hensley, Patrick J., Roland Seiler, Harry W. Herr, et al.. (2023). Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1. Urologic Oncology Seminars and Original Investigations. 41(7). 307–312. 1 indexed citations
5.
6.
Agaimy, Abbas, Ralf J. Rieker, J. Dörsam, et al.. (2018). Immunoglobulin-g4(IgG4)-rich Pseudotumor of the Kidney – A case report and review of the literature. Journal of IMAB - Annual Proceeding (Scientific Papers). 24(1). 1872–1877. 2 indexed citations
7.
Hessels, Daphne, Tim M. Govers, Wim Van Criekinge, et al.. (2018). COST-EFFECTIVENESS OF SELECTMDX FOR PROSTATE CANCER IN FOUR EUROPEAN COUNTRIES: A MODELLING STUDY. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
8.
Bolenz, Christian, Bernd Schröppel, A. Eisenhardt, Bernd J. Schmitz‐Dräger, & Marc‐Oliver Grimm. (2018). The Investigation of Hematuria. Deutsches Ärzteblatt international. 115(48). 801–807. 47 indexed citations
9.
10.
Schmitz‐Dräger, Bernd J., et al.. (2011). Sekundär- und Tertiärprävention urologischer Tumore. Der Urologe. 50(10). 1283–1287. 1 indexed citations
11.
Eugene, K., Christian Schwentner, Paul J. Christos, et al.. (2011). Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study. European Urology. 61(1). 185–192. 37 indexed citations
12.
Schmitz‐Dräger, Bernd J., et al.. (2010). Rolle der Immunzytologie in der Abklärung von Patienten mit schmerzloser Makrohämaturie. Der Urologe. 49(6). 741–746. 4 indexed citations
13.
Helpap, B., Bernd J. Schmitz‐Dräger, Peter W. Hamilton, et al.. (2003). Molecular pathology of non-invasive urothelial carcinomas (part I). Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 442(4). 309–316. 32 indexed citations
14.
Jankevičius, Feliksas, et al.. (2002). p21 and p53 Immunostaining and Survival following Systemic Chemotherapy for Urothelial Cancer. Urologia Internationalis. 69(3). 174–180. 16 indexed citations
15.
Florl, Andrea R., Roswitha Löwer, Bernd J. Schmitz‐Dräger, & Wolfgang A. Schulz. (1999). DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. British Journal of Cancer. 80(9). 1312–1321. 208 indexed citations
16.
Aleksic, M., et al.. (1998). Indikationsstellung und Verlauf bei der totalen pelvinen Exenteration. Der Chirurg. 69(4). 450–454. 1 indexed citations
17.
Schulz, Wolfgang A., et al.. (1998). WAF1/p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines.. International Journal of Oncology. 12(3). 621–8. 15 indexed citations
18.
Schmitz‐Dräger, Bernd J., et al.. (1997). c-myc in bladder cancer Clinical findings and analysis of mechanism. Urological Research. 25(S1). S45–S49. 31 indexed citations
19.
Schmitz‐Dräger, Bernd J., et al.. (1994). Establishment and characterization of human renal cancer cell lines and autologous normal kidney short term cultures.. PubMed. 5. 35–41. 2 indexed citations
20.
Schmitz‐Dräger, Bernd J., Marc‐Oliver Grimm, Claus‐Dieter Gerharz, et al.. (1994). P53 accumulation in precursor lesions and early stages of bladder cancer. World Journal of Urology. 12(2). 79–83. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Eto Breakdown of academic impact, for papers by T.R. Leyshon Griffiths Breakdown of academic impact, for papers by Yasutomo Nakai Breakdown of academic impact, for papers by Jeremy Crew Breakdown of academic impact, for papers by Toshihiko Kotake Breakdown of academic impact, for papers by Miao‐Fen Chen Breakdown of academic impact, for papers by Rainy Umbas Breakdown of academic impact, for papers by Frank Perabo Breakdown of academic impact, for papers by Erik Veskimäe Breakdown of academic impact, for papers by Noboru Hara
Rankless by CCL
2026